These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

582 related items for PubMed ID: 23178916

  • 21. Itching is a significant problem and a mediator between disease severity and quality of life for patients with psoriasis: results from a randomized controlled trial.
    Zhu B, Edson-Heredia E, Guo J, Maeda-Chubachi T, Shen W, Kimball AB.
    Br J Dermatol; 2014 Nov; 171(5):1215-9. PubMed ID: 24749812
    [Abstract] [Full Text] [Related]

  • 22. Early treatment of psoriatic arthritis is associated with improved patient-reported outcomes: findings from the etanercept PRESTA trial.
    Kirkham B, de Vlam K, Li W, Boggs R, Mallbris L, Nab HW, Tarallo M.
    Clin Exp Rheumatol; 2015 Nov; 33(1):11-9. PubMed ID: 25535650
    [Abstract] [Full Text] [Related]

  • 23. Comparison of Adalimumab and Etanercept for the Treatment of Moderate to Severe Psoriasis: An Indirect Comparison Using Individual Patient Data from Randomized Trials.
    Papp KA, Yang M, Sundaram M, Jarvis J, Betts KA, Bao Y, Signorovitch JE.
    Value Health; 2018 Jan; 21(1):1-8. PubMed ID: 29304933
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Secukinumab efficacy in the treatment of nail psoriasis: a case series.
    Pistone G, Gurreri R, Tilotta G, Castelli E, Bongiorno MR.
    J Dermatolog Treat; 2018 Jan; 29(sup1):21-24. PubMed ID: 30273068
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Adalimumab in the treatment of moderate-to-severe chronic plaque psoriasis in patients switching from other biologics.
    Sator P, Richter L, Saxinger W, Vasiljevic M, Stingl G.
    J Eur Acad Dermatol Venereol; 2015 Sep; 29(9):1742-9. PubMed ID: 25665143
    [Abstract] [Full Text] [Related]

  • 30. Real-life 9-year experience with adalimumab in psoriasis and psoriatic arthritis: results of a single-centre, retrospective study.
    Chiricozzi A, Zangrilli A, Bavetta M, Bianchi L, Chimenti S, Saraceno R.
    J Eur Acad Dermatol Venereol; 2017 Feb; 31(2):304-311. PubMed ID: 27324646
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Clinical and Patient-reported Outcomes in Patients with Psoriatic Arthritis (PsA) by Body Surface Area Affected by Psoriasis: Results from the Corrona PsA/Spondyloarthritis Registry.
    Mease PJ, Karki C, Palmer JB, Etzel CJ, Kavanaugh A, Ritchlin CT, Malley W, Herrera V, Tran M, Greenberg JD.
    J Rheumatol; 2017 Aug; 44(8):1151-1158. PubMed ID: 28620063
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The long-term safety of adalimumab treatment in moderate to severe psoriasis: a comprehensive analysis of all adalimumab exposure in all clinical trials.
    Leonardi C, Papp K, Strober B, Reich K, Asahina A, Gu Y, Beason J, Rozzo S, Tyring S.
    Am J Clin Dermatol; 2011 Oct 01; 12(5):321-37. PubMed ID: 21834597
    [Abstract] [Full Text] [Related]

  • 38. Effects of Apremilast on Pruritus and Skin Discomfort/Pain Correlate With Improvements in Quality of Life in Patients With Moderate to Severe Plaque Psoriasis.
    Sobell JM, Foley P, Toth D, Mrowietz U, Girolomoni G, Goncalves J, Day RM, Chen R, Yosipovitch G.
    Acta Derm Venereol; 2016 May 01; 96(4):514-20. PubMed ID: 26837052
    [Abstract] [Full Text] [Related]

  • 39. Ixekizumab treatment of biologic-naïve patients with active psoriatic arthritis: 3-year results from a phase III clinical trial (SPIRIT-P1).
    Chandran V, van der Heijde D, Fleischmann RM, Lespessailles E, Helliwell PS, Kameda H, Burgos-Vargas R, Erickson JS, Rathmann SS, Sprabery AT, Birt JA, Shuler CL, Gallo G.
    Rheumatology (Oxford); 2020 Oct 01; 59(10):2774-2784. PubMed ID: 32031665
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.